Evidence map›Paper›PMID 37366870›Full record

ArticleDiseases (Basel, Switzerland)2023

Factors Associated with Reclosure of Posterior Capsule Aperture by Flat Opacifications with Pearls after Nd:YAG Laser Posterior Capsulotomy.

Akiko Ota, Ichiro Ota, Shu Kachi, Goichiro Miyake, Fuminori Haga, Kensaku Miyake, Mineo Kondo, Kumiko Kato

Abstract read
In one paragraph

Article in Diseases (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Akiko OtaDepartment of Ophthalmology, Mie University Graduate School of Medicine, Tsu 5148507, Japan.
Ichiro OtaShohzankai Medical Foundation, Miyake Eye Hospital, Nagoya 4620825, Japan.
Shu KachiShohzankai Medical Foundation, Miyake Eye Hospital, Nagoya 4620825, Japan.
Goichiro MiyakeShohzankai Medical Foundation, Miyake Eye Hospital, Nagoya 4620825, Japan.
Fuminori HagaShohzankai Medical Foundation, Miyake Eye Hospital, Nagoya 4620825, Japan.
Kensaku MiyakeShohzankai Medical Foundation, Miyake Eye Hospital, Nagoya 4620825, Japan.
Mineo KondoDepartment of Ophthalmology, Mie University Graduate School of Medicine, Tsu 5148507, Japan.
Kumiko KatoDepartment of Ophthalmology, Mie University Graduate School of Medicine, Tsu 5148507, Japan.ORCID 0000-0003-4172-3443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this retrospective case series, we investigated factors associated with posterior capsule aperture (PCA) reclosure following neodymium-yttrium aluminum garnet (Nd:YAG) laser posterior capsulotomy. The study encompassed patients who underwent cataract surgery with intraocular lens (IOL) implantation or a combined vitrectomy, cataract surgery, and IOL implantation between 2009 and 2022. PCA reclosure was observed in 22 eyes of 17 patients: 45% (10 eyes) underwent the triple procedure, and 55% (12 eyes) received cataract surgery with IOL implantation. In our clinic, 14% of patients were given IOLs with a 4% water content, while 73% (13 eyes) of those experiencing PCA reclosure had IOLs with a 4% water content. The mean interval between Nd:YAG capsulotomies was notably shorter than that between the initial cataract surgery and the first Nd:YAG laser capsulotomy. We also identified five stages of PCA reclosure progression. In conclusion, IOL water content may be linked to PCA reclosure, and the time to recurrence is shorter with each successive reclosure. Further research is needed to verify these findings and uncover additional contributing factors.

Indexed as

Elschnig pearlsNd:YAG laser capsulotomyposterior capsule apertureposterior capsule opacificationreclosurere-opacificationwater content of IOL

Identifiers

PMID37366870
PMCPMC10296942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.